Brimonidine-associated uveitis – a descriptive case series

Bilateral granulomatous uveitis as a side effect of topical brimonidine: two case reports.

An 80 year old female in good general health was diagnosed with normal tension glaucoma and was prescribed Alphagant (brimonidine tartarate 0.2%) twice daily in both eyes. The intraocular pressure decreased from 15 mmHg to 11 mmHg bilaterally. The patient did not complain of any side effects when using the brimonidine drops. Exactly one year later, she presented with a sudden onset of chemosis,...

Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series.

Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon

Withdrawal pain can be a barrier to opioid cessation. Yet, little is known about old injury site pain in this context. We conducted an exploratory mixed-methods descriptive case series using a web-based survey and in-person interviews with adults recruited from pain and addiction treatment and research settings. We included individuals who self-reported a past significant injury that was healed...

Cancrum Oris - a Descriptive Case Series on 13 Patients

Objectives: To evaluate the age, gender, site distribution and associated systemic debelitating conditions (if any) of the patients with Cancrum Oris. Methodology: A descriptive retrospective study was undertaken in the Oral and Maxillofacial Surgery unit of Khyber College of Dentistry from January 2005 to January 2010. Information regarding the variables of the study i.e., age, gender, site di...

Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series

Uveitis treatment involves topical corticosteroids along with cycloplegic-mydriatics. Particularly severe cases may require systemic corticosteroids and immunosuppressive drugs. Vernal keratoconjunctivitis (VKC) treatment consists of a brief period of topical corticosteroids and/or cyclosporine. In patients refractory to traditional treatment, the use of 0.1% topical ophtalmic FK- 506 (tacrolim...